STAAR SURGICAL CO
For the period ended Oct 2, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 2, 2026 · Filed Nov 4, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-07-03; filed 2026-08-12.
0000718937-26-000037
Item 1A. RISK FACTORSCurrent report: 10-Q
Period ended 2026-10-02; filed 2026-11-04.
0000718937-26-000041
Item 1A. RISK FACTORSUNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 1 previous paragraphs and 3 current paragraphs.
1 unchanged; 0 reworded; 2 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (2)
Current report
The following table summarizes the Company’s share repurchase activity for the three months ended October 2, 2026, on a monthly basis:
Current report
On September 24, 2026, the Company announced that its Board of Directors authorized a share repurchase program under which the Company may repurchase up to $50.0 million of its outstanding common stock for a term expiring on September 24, 2027. During the three months ended October 2, 2026 the Company did not repurchase any of its shares under the share repurchase program. As of October 2, 2026, $50.0 million remained available for repurchases pursuant to our share repurchase program. The share repurchase program is expected to continue over the next twelve months, unless extended or shortened by the Board of Directors. The Company’s prior share repurchase program, announced in May 2025, expired according to its terms on or about May 15, 2026. Under the share repurchase program, the Company may repurchase shares in the open market, through privately negotiated transactions, by entering into structured repurchase agreements with third parties, and/or other standard mechanisms. The timing, manner, price, and amount of any repurchases under the program will be determined by the Company in its discretion, subject to market conditions, legal requirements, and other considerations. The Company is not obligated to repurchase any specific number of shares, and the program may be modified, suspended, or discontinued at any time, without prior notice.